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Abstract
Background: Systematic reviews are important for decision-makers. They offer many potential benefits but are often
written in technical language, are too long, and do not contain contextual details which makes them hard to use for
decision-making. There are many organizations that develop and disseminate derivative products, such as evidence
summaries, from systematic reviews for different populations or subsets of decision-makers. This systematic review will
assess the effectiveness of systematic review summaries on increasing policymakers’ use of systematic review evidence
and to identify the components or features of these summaries that are most effective.
Methods/design: We will include studies of policy-makers at all levels as well as health-system managers. We will
include studies examining any type of “evidence summary,” “policy brief,” or other products derived from systematic
reviews that present evidence in a summarized form. The primary outcomes are the following: (1) use of systematic
review summaries decision-making (e.g., self-reported use of the evidence in policy-making, decision-making) and
(2) policy-maker understanding, knowledge, and/or beliefs (e.g., changes in knowledge scores about the topic included
in the summary). We will conduct a systematic review of randomized controlled trials (RCTs), non-randomized
controlled trials (NRCTs), controlled before-after studies (CBA), and interrupted time series (ITS) studies.
Discussion: The results of this review will inform the development of future systematic review summaries to ensure
that systematic review evidence is accessible to and used by policy-makers making health-related decisions.
Keywords: Systematic reviews
Background
Systematic reviews are becoming increasingly important
for policy-makers making decisions [1–3]. Systematic
reviews offer many potential benefits to policy-makers,
including identifying interventions that are effective (or
not effective), are considered to have lower risk of bias
than other studies, and offer more confidence in results
than single studies [2]. However, most systematic reviews
are written using technical language, are too long, and do
not describe contextual information important for policy-
makers and other users making decisions about how to
use the evidence [4].
Policy-makers include health ministers and their polit-
ical staff, civil servants, and health-system stakeholders
(i.e., civil society groups, patient groups, professional
associations, non-governmental organizations, donors,
international agencies [5].
Within the Cochrane Collaboration, the Evidence Aid
Project was developed in response to the 2004 Indian
Ocean Tsunami as a means of providing decision-makers
and health practitioners “on the ground” with summaries of
the best available evidence needed to respond to emergen-
cies and natural disasters [6]. A needs assessment con-
ducted by Evidence Aid staff found that systematic
review summaries could improve understanding of
users (i.e., NGOs, health care providers) so that they
can make decisions on the applicability of the findings
to their local setting [6]. These user-friendly formats
highlight the policy-relevant information and allow
policy-makers to quickly scan the document for rele-
vance [2, 7].
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In addition to Evidence Aid, there are many organiza-
tions that develop and disseminate evidence summaries
for different populations or subsets of decision-makers.
For example, SUPPORT Summaries were developed for
policy-makers in low- and middle-income countries
making decisions about maternal and child health pro-
grams and interventions (http://www.supportsummarie-
s.org/support-summaries). Health Systems Evidence
provides policy briefs for policy-makers making
health-systems decisions (www.
healthsystemsevidence.org/). Communicate to vaccin-
ate (COMMVAC) is creating user-friendly summaries
to translate evidence on vaccination communication
for policymakers and the community in LMICs (http://
www.commvac.com). Rx for change is a searchable data-
base for evidence about intervention strategies to alter be-
haviors of health technology prescribing, practice, and use
(www.cadth.ca/resources/rx-for-change). In fact, Lavis et
al. identified 16 organizations involved in the production
of summaries for policymakers in low- and middle-
income countries [8].
These summaries may be called evidence summar-
ies, policy briefs, briefing papers, briefing notes, evi-
dence briefs, abstracts, summary of findings, and plain
language summaries [8]. They consist of summarized
evidence from systematic reviews intended to assist
policy-makers in understanding the systematic review
evidence and using it in their decision-making. These
interventions may include structured summaries (e.g.,
SUPPORT summaries, Evidence Aid), policy briefs which
are based on systematic reviews (e.g., Health Systems Evi-
dence), and plain language summaries, structured abstracts,
and Summary of Findings tables (e.g., Cochrane reviews).
These may be provided in print or web-based formats and
are aimed at policy-makers, and other decision-makers
making decisions about health. The summaries may in-
clude information about the context in which the stud-
ies were conducted, the applicability of the results (e.g.,
SUPPORT Summaries comment on the relevance of
the findings for disadvantaged communities), as well as
the findings, methods, and conclusions.
Previously conducted systematic reviews have looked
at interventions to increase the use of systematic reviews
among decision-makers. For example, Murthy et al. con-
ducted a systematic review examining the effectiveness
of interventions for improving the use of systematic re-
views in decision-making by health-system managers,
policy-makers, and clinicians [9]. Eight studies were
included and the authors concluded that information
provided as a single, clear message may improve evidence-
based practice, but increasing awareness and knowledge of
systematic review evidence might require a multi-faceted
intervention. Similarly, Perrier et al. conducted a systematic
review of interventions encouraging the use of systematic
reviews by health policymakers and managers [10]. Four
studies were included in the systematic review and the
authors concluded that future research should identify how
systematic reviews are accessed and the formats used to
present the information. Finally, a review by Wallace et al.
found that the facilitators to increase systematic review use
by policymakers included description of benefits as well as
harms and costs, and using a 1:3:25 staged approach to
evidence summaries [11]. However, none of these reviews
were focused on summaries created from systematic
reviews.
Therefore, this review aims to assess the effectiveness
of systematic review summaries on increasing policy-
makers’ use of systematic review evidence and to identify
the components or features of these summaries that are
most effective.
Objectives
The objectives of this review are to (1) assess the effect-
iveness of evidence summaries on policy-makers’ use of
the evidence and (2) identify the most effective compo-




We will include randomized controlled trials (RCTs),
non-randomized controlled trials (NRCTs), controlled
before-after studies (CBA), and interrupted time series
(ITS) studies.
Types of participants
We will include studies which include health policy-
makers at all levels (including civil society organization
staff, non-governmental organization staff, local govern-
ment staff, federal government staff) and health system
managers making decisions on behalf of a large jurisdiction
or organization (6). We will not include studies related to
decision-making for an individual person or patient.
Types of interventions
We will include studies examining any type of “friendly
front end,” “evidence summary,” or “policy brief” or other
product derived from systematic reviews or guidelines
based on systematic reviews that presents evidence in a
summarized form to policy-makers and health system
managers. Interventions must include a summary of a sys-
tematic review and be actively “pushed” to target users.
For example, a potentially included study used an inter-
vention that evaluated the effectiveness of friendly front
ends by assessing changes in policy-maker beliefs [12]. An
example of a study that would be excluded assessed the
views of policymakers on how systematic reviews can be
promoted within a low- and middle-income country [13].
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We will exclude studies in which evidence summaries
are one component of a multi-component intervention.
Comparison
We will include any comparisons including active com-
parators (e.g., other summary formats) or no intervention.
Types of outcome measures
Primary Outcomes
The primary outcomes are the following:
1. Use of systematic review derivative product in
decision-making (e.g., self-reported use of the
evidence in policy-making and decision-making as
well as self-reported access of research, appraisal of
research, or commissioning of further research
within the decision-making process [14]. We
will include instrumental use of research in
decision-making (e.g., direct use of research) as
well as conceptual use (e.g., using research to gain
an understanding of a problem or intervention) and
symbolic use (e.g., using research to confirm a
policy/program already implemented) [15].
2. Understanding, knowledge, and/or beliefs
(e.g., changes in knowledge scores about the
topic included in the summary).
Secondary Outcomes
We will also include studies that report on any of the
following outcomes:
 Perceived relevance of systematic review summaries
 Perceived credibility of the summaries
 Perceived usefulness and usability of systematic
review summaries
 Perceptions and attitudes regarding the specific
components of the summaries and their
usefulness
 Understandability of summaries
 Desirability of summaries (e.g., layout, selection of
images, etc) [4]
We recognize that some studies may use different
terms to describe these outcomes. For example, the
term “satisfaction” maybe used as an umbrella term to
capture relevance, usability, and desirability. These out-
comes will be assessed by the team and categorized
according to the above list.
This systematic review has not been registered with
PROSPERO since there we are not assessing health
outcomes.
Search methods for identification of studies
An information specialist will help develop the search
strategy using the PRESS Guideline [16]. We will build on
the search strategy used by Perrier et al. and Murthy et al.
in their systematic reviews of interventions to encourage
the use of systematic reviews by health managers and
policy-makers [9, 10].
Electronic searches
The search conducted by Perrier et al. identified
11,297 records (after removing duplicates) and in-
cluded four papers reporting two studies. We will ex-
pand this search by including additional databases, as
suggested by John Eyres, of the International Initiative
for Impact Evaluation (3ie) and the Campbell International
Development Review Group. These include databases such
as Global Health (CABI), Global Health Library (from
WHO), Popline, Africa-wide, Public Affairs Information
Service, Worldwide Political Science Abstracts, Web of
Science, and DfiD (Research for Development Database)
(see Additional file 1).
Searching other resources
We will search websites of research groups and organiza-
tions producing evidence summaries to identify unpub-
lished studies evaluating the effectiveness of the systematic
review derivatives in increasing policy-makers’ under-
standing (e.g., Health Systems Evidence, the Canadian
Agencies for Health Technology Assessment, SUPPORT
Summaries).
We will check reference lists of relevant studies to iden-
tify additional studies. We will contact researchers to iden-
tify ongoing and completed/published work. We will report
the results of the search using the PRISMA flow diagram.
Data collection and analysis
Selection of studies
Two reviewers will independently screen titles and
abstracts to identify relevant studies meeting the pre-
specified inclusion criteria. The full text of potentially
included studies will be screened independently by two
authors. Data extraction and quality assessment will be
conducted independently and in duplicate. We will use
software Covidence (https://www.covidence.org/) for
screening of studies. All completed studies will be in-
cluded if they meet the inclusion criteria listed above.
Data extraction and management
The data extraction form will be pre-tested and will in-
clude factors related to the population, intervention,
comparison, and outcomes. The data will be extracted
independently in duplicate by two reviewers using a
structured Excel sheet and will be piloted on ten articles.
Disagreements on extractions will be resolved by
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discussion and with a third member of the research team
when necessary Evidence summaries, like systematic re-
views, that seek to inform decisions in a neutral way
should not contain recommendations. Therefore, sum-
maries that provide recommendations will be assessed
separately from those without recommendations since
these may affect the user experience [17].










 Type of evidence summary
 Format of evidence summary
 Description of evidence summary components
(e.g., descriptions of easy-to-skim formatting,
graded entry, use of tables/figures) [18]
 Mode of delivery
 Topic of evidence summary
 Recommendation of evidence summary
 Outcomes
 Policy/decision-makers’ self-reported use of
summaries in decision-making
 Policy/decision-makers’ knowledge of the
summary content and the measurement used
 Policy/decision-makers’ understanding and
measurement used
 Perceived relevance of the summaries and
measurement used
 Perceived credibility of the summaries and
measurement used
 Perceived usefulness and usability of the
summaries and measurement used
 Perceived understandability of the summaries and
measurement used
 Perceived desirability of the summaries and
measurement used
 Process indicators
 How the systematic review was selected for
summary (e.g., based on topic, quality criteria)
 How the evidence summary was developed (e.g.,
iterative process)
 Involvement of stakeholders in evidence
summary development—which stakeholders,
description of involvement
Assessment of risk of bias in included studies
The methodological quality will be specifically examined
using the risk of bias tools from the Cochrane Handbook
for randomized trials and the Effective Practice and
Organization of Care (EPOC) Review Group criteria
for interrupted time series and controlled before-after
studies [19, 20] and A Cochrane Risk Of Bias Assessment
Tool: for Non-Randomized Studies of Interventions
(ACROBAT-NRSI) [21].
Measures of treatment effect
Effect estimates and confidence intervals for individual
studies will be calculated (where possible) irrespective of
whether a pooled effect estimate is calculated. When it
is possible to combine studies, dichotomous outcomes
will be reported as relative risks. Continuous outcomes
will be reported as weighted mean differences. If an
outcome has been reported in different scales (e.g.,
understanding), and we consider the scales to measure a
similar construct, standardized mean differences will be
used to summarize the data. When it is not possible to
combine the data, we will present the results for each
study separately.
Unit of analysis issues
When possible, any studies with cluster allocation (e.g.,
cluster-randomized trials, cluster-allocated controlled be-
fore and after studies, and interrupted time series) ana-
lyses with errors in the unit of analysis will be adjusted
using the variance inflation factor, as described in the
Cochrane Handbook, if the necessary data can be ob-
tained from the study authors. We will obtain ICC from
other similar studies with similar outcomes if the ICC is
not published (e.g., by checking the Aberdeen website
of ICCs, http://www.abdn.ac.uk/hsru/research/delivery/
behaviour/methodological-research/ or the Campbell
Collaboration website of ICCs for education). Sensitivity
analyses will be used to assess the effects of incorporating
these corrected analyses in our analysis.
Dealing with missing data
We will attempt to contact the contact author of the stud-
ies by email for any missing data.
Assessment of heterogeneity
If meta-analysis is possible, we will explore heterogeneity
using forest plots and the I2 statistic according to guid-
ance of the Cochrane Handbook for Systematic Reviews
of Interventions [19].
Assessment of reporting biases
If more than ten studies are included, we will use funnel
plots to explore publication bias.
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Data synthesis
Where appropriate, results will be synthesized using
meta-analysis. We will present the relative risks using
random effects models for dichotomous outcomes and
standardized mean differences for continuous out-
comes. When studies have reported the same outcome
using different scales, we will use standardized mean
differences. Non-randomized studies will be meta-
analyzed separately from RCTs. When results cannot be
pooled, we will present a narrative summary of the
results.
We will analyze the results of qualitative data from in-
cluded studies, when possible, to understand the percep-
tions and attitudes regarding the components of the
summaries that were considered the most useful.
Assessing the methodological quality
We will use the Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE) approach to
assess the quality of evidence for the outcomes reported
in this review [22].
Subgroup analysis and investigation of heterogeneity
Heterogeneity will be explored, if possible, by conduct-
ing meta-regression to assess the role of mediating fac-
tors, including the following:
 Target audience of summary (e.g., focused on
specific local context, generic summary)
 Type of decision maker (e.g., federal policy-maker
versus hospital administrator)
 Components of friendly front end (e.g., bulleted list,
text, summary of findings table, causal chain)
Sensitivity analysis
The impact of including studies assessed as high risk of
bias or studies in which there were unit of analysis errors
that could not be reanalyzed will be considered in sensitiv-
ity analysis.
Applicability
We will assess applicability of the findings of the review
to specific settings of relevance to end-users. We will
use the most up to date methods from the Cochrane
Applicability and Recommendations Methods Group
which include assessing the directness of the evidence
to specified settings of interest using GRADE [23].
Discussion
This review will summarize the evidence on the use of
systematic review summaries in policy-making and
policy-makers’ understanding of systematic review evi-
dence, and assess evidence about different components
and design features. To the best of our knowledge, this
is the first systematic review to assess the use of
systematic review summaries in policy-making. The
results of this review will inform researchers and sys-
tematic review summary developers of the best way to
present the evidence to ensure that evidence summar-
ies fulfill their goal of informing policy-makers with
the best possible evidence needed to make health-
related decisions.
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